Outro Announces $7M in Funding to Expand Access to Safe Deprescribing, Starting With AntidepressantsOutro, the first neuroscience-based platform helping Americans safely discontinue psychiatric medications, today announced $7 million funding across pre-seed and seed rounds, with participation from Listen Ventures, Cake Ventures, Jason Calicanis’s LAUNCH, Actions Capital, Hannah Grey VC, SemperVirens, Brock Recovery Group, Pave Health Ventures, and more.
Antidepressant Tapering Platform Outro Launches in Canada Ahead of World Tapering Day
Outro, the first-of-its-kind platform harnessing technology and specialized care to help people reduce or stop the use of antidepressants, announces its launch in Canada ahead of World Tapering Day on November 5. Outro’s user-friendly platform provides science-based, personalized tapering plans to slowly reduce medication dosage. It also provides proactive symptom monitoring, one-on-one chats and video appointments with practitioners trained specifically in safely stopping antidepressants, and a patient-first approach that minimizes risk of relapse and maximizes the chance of successful tapering.
